St. Louis, MO, United States of America

Thomas Darling

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Saint Louis University. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Darling. Retrieved from https://idiyas.com/inventor/thomas-darling

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thomas Darling: Innovator in Blood Brain Barrier Research

Introduction

Thomas Darling is a notable inventor based in Saint Louis, MO (US). He has made significant contributions to the field of neuroscience, particularly in the modulation of blood brain barrier protein expression. His work aims to enhance the effectiveness of drugs while minimizing their side effects.

Latest Patents

Thomas Darling holds a patent for the modulation of blood brain barrier proteins (BBBP). This patent discloses agents that inhibit BBBP, which are useful in controlling the entry and exit of agents in the central nervous system (CNS). This innovation allows for drugs to be more effective and helps in reducing the side effects associated with them.

Career Highlights

Darling is affiliated with Saint Louis University, where he conducts his research and development. His work has garnered attention for its potential impact on drug delivery systems and treatment efficacy in neurological disorders.

Collaborations

He collaborates with esteemed colleagues such as William A. Banks and Vijaya B. Kumar, who contribute to the advancement of research in this critical area.

Conclusion

Thomas Darling's innovative work in blood brain barrier research exemplifies the importance of scientific advancements in medicine. His contributions are paving the way for more effective treatments in the field of neuroscience.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…